期刊
RESPIRATORY INVESTIGATION
卷 55, 期 3, 页码 229-251出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.resinv.2017.01.002
关键词
Biological agent; Lung complication; Airway disease; Interstitial lung disease; Rheumatoid arthritis
资金
- Chugai Pharmaceutical Co.
- Takeda Pharmaceutical Co. Ltd.
- Eisai Co., Ltd.
- Ayumi Pharmaceutical Co.
- Mitsubishi-Tanabe Pharma
- Takeda Pharmaceutical Company Ltd.
- Pfizer Japan Inc.
- Bristol-Myers Squibb
- Astellas Pharma Inc.
- Grants-in-Aid for Scientific Research [15K09535] Funding Source: KAKEN